Literature DB >> 19664394

[Association of CK20 expression with the progression, metastasis and prognosis of breast cancer].

Shou-man Wang1, Da-mao Huang, Bo Li, Jing-de Ruan.   

Abstract

AIM: To analyze the expression of CK20 in human breast cancer, and to evaluate the association between its expression and tumor's progression and prognosis.
METHODS: 86 cases with breast cancer, 20 cases of benign tumor tissues were examined for the expression of CK20 by immunohistochemical staining.
RESULTS: The positive rate of CK20 expression in breast cancer was 80.23% (69/86), which was significantly higher than that in benign tumor tissues of breast [20.00% (4/20), P<0.01]. CK20 expression was associated with the histologic grades (P<0.05) and the pathological types (P<0.01). The expression of CK20 was observed to correlate positively with TNM stages (r=0.86, P<0.05), lymph node status (r=0.73, P<0.05) and HER-2 status (r=0.69, P<0.05), and correlate negatively with ER status (r=-0.58, P<0.05). Moreover, Kaplan Meier curves of overall survival analysis showed a significant difference between CK20 positive groups and negative group (P<0.01).
CONCLUSION: The results suggest that the expression of CK20 may be associated with the progression and prognosis of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19664394

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  2 in total

1.  Metastasis to the breast from colonic adenocarcinoma.

Authors:  Kyoung Tae Noh; Boyoung Oh; Sun Hee Sung; Ryung-Ah Lee; Soon Sup Chung; Byung In Moon; Kwang Ho Kim
Journal:  J Korean Surg Soc       Date:  2011-11-25

2.  Keratin expression in breast cancers.

Authors:  Mu-Min Shao; Siu Ki Chan; Alex M C Yu; Christopher C F Lam; Julia Y S Tsang; Philip C W Lui; Bonita K B Law; Puay-Hoon Tan; Gary M Tse
Journal:  Virchows Arch       Date:  2012-08-01       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.